UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

09/01/2021 20:01

https://mb.cision.com/Public/18595/3265694/825ec5b01cc38f49_800x800ar.jpg ** Disposals of own shares ------------------------------------------------------------ Brussels (Belgium), 8 January 2021 =E2=80=93 20:00 (CET) =E2=80=93 regulate= d information In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the = =E2=80=9CCompany) (Euronext Brussels: UCB) announces that, following exerci= ses of stock options by members of its personnel, it has disposed of UCB sh= ares OTC in view of deliveries of these shares to the relevant members of t= he personnel, within the framework of the Long Term Incentive Program of th= e UCB Group, as follows: https://mb.cision.com/Public/18595/3265694/8d9662aa0170cf1f_800x800ar.png =C2=A0 This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://www.ucb.com/stories-media/Press-Releases) . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i= n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news GenericFile 210109 - Disposals of own shares (https://mb.cision.com/Public/18595/326569= 4/b2f79f0b767fb0d4.pdf) GenericFile 210109 - Ali=C3=A9nation d actions propres (https://mb.cision.com/Public/18= 595/3265694/936a6e4514dbb644.pdf) GenericFile 210109 - Vervreemding van eigen aandelen (https://mb.cision.com/Public/1859= 5/3265694/9b09721b4e55c011.pdf) Image chart 1 Jan 9 2021 (https://mb.cision.com/Public/18595/3265694/8d9662aa0170= cf1f_org.png)=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x57921x1x6868579x24000= x6&Email=3Dregnews%40symexglobal.com.=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

UCB's latest news

25/04/2024 18:00

UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

UCB's latest news

Other stories